GLP-1s have changed the conversation around metabolic health—but it shouldn’t stop at weight loss. Emerging evidence points to broader benefits across liver health, kidney function, cardiovascular risk, and more. This session explores the expanding clinical landscape, what it means for employer benefit strategy, and how employers are balancing access with long-term affordability and plan sustainability.